Search Results For :: patient engagement
-
AI in Biotechnology Market by Function (Drug Design & Optimization, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply Chain, Logistics; Launch, Pricing, Patient Engagement, Adverse Events) and End User - Global Forecast to 2035
The global AI in biotechnology market, valued at US$3.51 billion in 2024, stood at US$4.16 billion in 2025 and is projected to advance at a resilient CAGR of 18.5% from 2024 to 2035, culminating in a forecasted valuation of US$22.72 billion by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
AI in Telehealth & Telemedicine Market by Component (Software, Service), Function (Virtual Care, Chatbot, RPM, Admin, Patient Engagement), Application (Teleneurology, TeleICU, Teleradiology), End User (Provider, Payer, Patient) - Global Forecast to 2030
The global AI in telehealth & telemedicine market, valued at US$2.85 billion in 2023, stood at US$4.22 billion in 2024 and is projected to advance at a resilient CAGR of 36.4% from 2024 to 2030, culminating in a forecasted valuation of US$27.14 billion by the end of the period. The market has experienced significant growth primarily driven by the growing geriatric and medically underserved (predominantly rural) population, the increasing prevalence of chronic conditions, the shortage of physicians and care personnel, advancements in telecommunication technologies, and the expansion of RPM systems.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Patient Engagement Solutions Market by Component (Hardware (Tablet)), Software (Integrated), Therapy (CVD, Diabetes), Functionality (Education, Scheduling), User (Provider, Payer (Public)), Unmet Need, Investment, Buying Criteria - Global Forecast to 2028
The global patient engagement solutions market, valued at US$19.6 billion in 2022, stood at US$22.5 billion in 2023 and is projected to advance at a resilient CAGR of 13.2% from 2023 to 2028, culminating in a forecasted valuation of US$41.8 billion by the end of the period. Factors such as the implementation of government regulations and initiatives to encourage patient-centric care, the growing demand for patient engagement solutions, the increasing number of collaborations and partnerships between stakeholders, and the rising use of mobile health apps are the factors driving the growth of this market.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
US Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer, ASC) - Forecast to 2030
The US Telehealth & Telemedicine Market, valued at US$46.10 billion in 2024, stood at US$51.40 billion in 2025 and is projected to advance at a resilient CAGR of 10.2% from 2025 to 2030, culminating in a forecasted valuation of US$83.63 billion by the end of the period. In the US, permanent CMS reimbursement expansions and state-level payment parity laws are driving telehealth growth by securing fair, ongoing reimbursement comparable to in-person care.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology), Age (Adults, Pediatrics), End User (Hospitals, ASCs, Payers) - Forecast to 2030
The Asia Pacific telehealth & telemedicine market, valued at US$18.22 billion in 2024, stood at US$21.04 billion in 2025 and is projected to advance at a resilient CAGR of 14.2% from 2024 to 2030, culminating in a forecasted valuation of US$40.83 billion by the end of the period. The growth of the telehealth and telemedicine market in the region is driven by rising demand for remote healthcare delivery, digital health platforms, and virtual care solutions that improve accessibility, efficiency, and cost-effectiveness across diverse population groups.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
AI in Biotechnology Market by Function (Drug Design & Optimization, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply Chain, Logistics; Launch, Pricing, Patient Engagement, Adverse Events) and End User - Global Forecast to 2035
The global AI in biotechnology market, valued at US$3.51 billion in 2024, stood at US$4.16 billion in 2025 and is projected to advance at a resilient CAGR of 18.5% from 2024 to 2035, culminating in a forecasted valuation of US$22.72 billion by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
AI in Telehealth & Telemedicine Market by Component (Software, Service), Function (Virtual Care, Chatbot, RPM, Admin, Patient Engagement), Application (Teleneurology, TeleICU, Teleradiology), End User (Provider, Payer, Patient) - Global Forecast to 2030
The global AI in telehealth & telemedicine market, valued at US$2.85 billion in 2023, stood at US$4.22 billion in 2024 and is projected to advance at a resilient CAGR of 36.4% from 2024 to 2030, culminating in a forecasted valuation of US$27.14 billion by the end of the period. The market has experienced significant growth primarily driven by the growing geriatric and medically underserved (predominantly rural) population, the increasing prevalence of chronic conditions, the shortage of physicians and care personnel, advancements in telecommunication technologies, and the expansion of RPM systems.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
NLP in Healthcare & Life Sciences Market by NLP Technique (OCR, NER, Sentiment Analysis), Application (Genomics & Precision Medicine, Patient Care & Engagement, Clinical Operations & Decision Support, Biomedical Research) - Global Forecast to 2030
The NLP in healthcare & life sciences market is expanding rapidly, with a projected market size anticipated to rise from about USD 5.18 billion in 2025 to USD 16.01 billion by 2030, featuring a CAGR of 25.3%. The major players in the NLP in healthcare & life sciences market include Microsoft (US), Google (US), IQVIA (US), Oracle (US), IBM (US), Lexalytics (US), Averbis (Germany), Emtelligent (Canada), Gnani.ai (India), and Deep 6 AI (US).
- Published: May 2025
- Price: $ 7150
- TOC Available:
-
Patient Engagement Solutions Market by Component (Hardware (Tablet)), Software (Integrated), Therapy (CVD, Diabetes), Functionality (Education, Scheduling), User (Provider, Payer (Public)), Unmet Need, Investment, Buying Criteria - Global Forecast to 2028
The global patient engagement solutions market, valued at US$19.6 billion in 2022, stood at US$22.5 billion in 2023 and is projected to advance at a resilient CAGR of 13.2% from 2023 to 2028, culminating in a forecasted valuation of US$41.8 billion by the end of the period. Factors such as the implementation of government regulations and initiatives to encourage patient-centric care, the growing demand for patient engagement solutions, the increasing number of collaborations and partnerships between stakeholders, and the rising use of mobile health apps are the factors driving the growth of this market.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Patient Engagement Technology an Innovative Tool for Healthcare Industry, Global End User Market Trends and Analysis - (Price Analysis, Replacement Trends and Factor Analysis, Selection Criteria, Buying Behavior and Mobile health)
The global patient engagement technology market growth is primed to transition from $17.3 billion in 2022 to $27.9 billion by 2027, showcasing a strong CAGR of 10.0%.
- Published: September 2022
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 71
